Occupational safety and health criteria for responsible development of nanotechnology

Journal of Nanoparticle Research

Volumn 16, Issue 1, 2014, Pages

  Schulte, P A ^a   Geraci, C L ^a   Murashov, V ^a   Kuempel, E D ^a   Zumwalde, R D ^a   Castranova, V ^a   Hoover, M D ^a   Hodson, L ^a   Martinez, K F ^a,b  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b Hassett Willis   (United States)

Author keywords

Environmental and health effects; Ethics; Regulation; Risk assessment; Risk management; Toxicology

Indexed keywords

ENVIRONMENTAL AND HEALTH EFFECTS; ETHICS; HAZARD AND RISK ASSESSMENTS; OCCUPATIONAL SAFETY AND HEALTH; POTENTIAL HAZARDS; REGULATION; TOXICOLOGY; WORKERS' EXPOSURES;

ENVIRONMENTAL REGULATIONS; HAZARDS; NANOSTRUCTURED MATERIALS; RISK ASSESSMENT; RISK MANAGEMENT;

NANOTECHNOLOGY;

NANOMATERIAL;

COMMERCIAL PHENOMENA; HEALTH HAZARD; HUMAN; NANOTECHNOLOGY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; OCCUPATIONAL SAFETY; PERIODIC MEDICAL EXAMINATION; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; SOCIETY; WORKER; WORKPLACE;

EID: 84889064826     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-013-2153-9     Document Type: Review

References (165)

1. - 78 Federal Register 36784 (2013) Survey of nanomaterial risk management practices. Centers for Disease Control and Prevention, Cincinnati
2. Aitken RJ, Creely KS, Tran CL (2004) Nanoparticles: an occupational hygiene review. Institute of Occupational Medicine, Edinburgh
3. Alloff E, Lin P (eds) (2008) Nanotechnology and society: current and emerging ethical issues. Springer, New York
4. American Textile Manufacturers Institute Inc. et al. versus Donovan 452 US 490 (1981) available at http://supreme.justia.com/cases/federal/us/452/490/ case.html. Accessed 3 Dec 2013
5. ANSES (2010) Development of a specific control banding tool for nanomaterials. French Agency for Food, Environmental and Occupational Health and Safety. No 2008-SA-0407, Córdoba
6. Antonini JM (2003) Health effects of welding. Crit Rev Toxicol 33(1):61-103
7. Ashford NA (1976) Crisis in the workplace: occupational disease and injury. MIT Press, Cambridge
8. BASF (2013) Nanotechnology code of conduct. http://www.basf.com/group/ corporate/en/about-basf/strategy/purpose-principles-values/code-of-conduct/ index. Accessed 16 Aug 2013
9. BAuA (Bundesanstalt für Arbeitsschutz und Arbeitsmedizin) (2007) Guidance for handling and use of nanomaterials at the workplace. http://www.baua.de/en/Topics-from-A-to-Z/Hazardous-Substances/Nanotechnology/ pdf/guidance.pdf?-blob=publicationFile&v=2. Accessed 16 Aug 2013
10. Bauer MW (2009) The evolution of public understanding of science-discourse and comparative evidence. Sci Technol Soc 14:221-240
11. Bayer Material Science (2010) Occupational exposure limit (OEL) for baytubes defined by Bayer material science. http://www.baytubes.com/news-and- services/news-09116-oel.html. Accessed 16 Aug 2013
12. Beaudrie CE, Kandlikar M, Satterfield T (2013) From cradle-to-grave at the nanoscale: gaps in US regulatory oversight along the nanomaterial life cycle. Environ Sci Technol 47:5524-5534
13. Berube DM (2006) Nano-hype: the truth behind the nanotechnology buzz. Prometheus Books, Amherst
14. Berube DM, Fabee B, Scheafela DA, Cummings CL, Barduer GE, Martin MS, Temple NM (2010) Communicating risk in the 21st century: the case of nanotechnology. An independent analysis commissioned by the NNCO, Arlington. http://www.nano.gw/sites/default/files/pub-resource/berube-risk-white-paper-feb- 2010.pdf. Accessed 16 Aug 2013
15. Bonner JC, Solva RM, Taylor AJ, Brown JM, Hilderbrand SC, Castranova V et al (2013) Inter laboratory evaluation of rodent pulmonary response to engineered nanoparticles. Environ Health Perspect 121:676-682
16. Boutou-Kempf O, Marchand J-L, Radauceanu A, Witschger O, Imbernon E, Health Risks of Nanotechnologies Group (2011) Development of a French epidemiological surveillance system of workers producing or handling engineered nanomaterials in the workplace. J Occup Environ Med 53(6):S103-S107
17. Brouwer DH (2012) Control banding approaches for nanomaterials. Ann Occup Hyg 56(5):506-514
18. Brouwer D, Berges M, Virgi M, Fransman W, Bello D, Hodson L, Gabriel S, Tielsmans E (2012) Harmonization of measurement strategies for exposure to manufractured nano-objects; report of a workshop. Ann Occup Hyg 56910:1-9
19. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K (2001) Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 175(3):191-199
20. BSI (2007) Nanotechnologies, part 2: guide to safe handling and disposal of manufactured nanomaterials. British Standards Institution, London, p 6699
21. Business Industrial Advisory Committee to the OECD (BIAC) (2013) Responsible development of nanotechnology turning vision into reality. http://www.biac.org/news/2013/1303-BIAC-Vision-Paper-on-Nanotechnology.htm. Accessed 26 Jul 2013
22. CalOSHA (2013) Worker responsibilities. http://www.dir.ca.gov/dosh/ workersrResponsibilities.htm. Accessed 16 Aug 2013
23. Canadian Standards Association (2012) Nanotechnologies - exposure control program for engineered nanomaterials in occupational settings. CSA Z-12885-12. Canadian Standards Association, Toronto
24. CEST (Commission de l' Ethique de la Science et de la Technologie) (2008) Ethics, risk, and nanotechnology: responsible approaches dealing with risk. In: Allhoff F, Lin P (eds) Nanotechnology and Society. Springer, DV, pp 75-89
25. Clark KA, White RH, Silbergeld EK (2011) Predictive models for nanotoxicology: current challenges and future opportunities. Regul Toxicol Pharmacol 59:361-363
26. Colvin V (2002) Responsible nanotechnology logic: looking beyond the good news. http://www.eurekalert.org/context.php?context=nano&show= essays&essaydate=1102. Accessed 26 Jul 2013
27. Cook WA (1945) Maximum allowable concentrations of industrial contaminants. Ind Med 14:936-946
28. Dahm MM, Evans DE, Schubauer-Berigan MK, Birch ME, Fernback JE (2012) Occupational exposure assessment in carbon nanotube and nanofiber primary and secondary manufacturers: mobile direct-reading sampling. An Occup Hyg 56(5):542-556. doi: 10.1093/annhyg/mer110
29. Dankovic D, Kuempel ED, Wheeler M (2007) An approach to risk assessment for TiO2. Inhal Toxicol 19:205-212
30. Dockery DW, Pope CA 3rd, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG Jr, Speizer FE (1993) An association between air pollution and mortality in six US cities. N Engl J Med 329(24):1753-1759
31. Dressen WC, Dallavale JM, Edwards JI, Miller JW, Sayers RR (1938) A study of asbestosis in the asbestos textile industry. US Treasury Department, Public Health Bulletin No. 241, Government Printing Office, Washington
32. Driscoll KE (1996) Role of inflammation in the development of rat lung tumors in response to chronic particle exposure. Inhal Toxicol 8:139-154
33. Duffin R, Tran CL, Clouter A (2002) The importance of surface area and specific reactivity in the acute pulmonary inflammatory response to particles. Ann Occup Hyg 46(Suppl 1):242-245
34. Eastlake A, Hodson L, Geraci CL, Crawford C (2012) A critical evaluation of material safety data sheets (MSDS) for engineered nanomaterials. J Chem Health Safety 19(5):1-8
35. Engeman CD, Baumgartner L, Carr BM et al (2012) Governance implications of nanomaterials companies inconsistent risk perceptions and safety practices. J Nanopart Res 14:749-761
36. EPA (2013) Significant new use rules on certain chemical substances. 40 CFR Parts 9 and 721. RIN 2070-AB27. Direct Rule. Federal Register Vol 78, Issue 152 (August 7, 2013)
37. EU-OSHA (2002) Workplace exposure to nanoparticles. European Agency for Safety and Health at Work, Bilbao
38. European Commission (2005) Nanosciences and nanotechnologies: an action plan for Europe 2005-2009. COM, Brussels, p 243
39. Falkner R, Jaspers N (2012) Regulating nanotechnologies: risk, uncertainty and the global governance gap. Global Environ Polit 12(1):30
40. Forloni G (2012) Responsible nanotechnology development. J Nanopart Res 14:1007
41. Gardiner K, van Tongeren M, Harrington M (2001) Respiratory health effects from exposure to carbon black: results of the phase 2 and 3 cross sectional studies in the European carbon black manufacturing industry. Occup Environ Med 58:496-503
42. Gewirth A (1986) Human-rights and the workplace. Am J Ind Med 9(1):31-40
43. Gibson R, Stacey N, Drais E, Wallin H, Zatorski W, Virpi V (2012) Risk perception and risk communication with regard to nanomaterials in the workplace. European Agency for Safety and Health at Work, Luxembourg
44. Hansen SF, Maynard A, Baun A, Tickner JA (2008) Late lessons from early warnings for nanotechnology. Nature Nanotechnol 3:444-447
45. Harthorn BH (2006) Nano-buzz: societal dimensions of emerging technologies. Anthropol News 47(7):26
46. Heinrich U, Fuhst R, Rittinghausen S, Creutzenberg O, Bellmann B, Koch W, Levsen K (1995) Chronic inhalation exposure of wistar rats and 2 different strains of mice to diesel-engine exhaust, carbon-black, and titanium-dioxide. Inhal Toxicol 7(4):533-556
47. Hett A (2004) Nanotechnology: small matter, many unknowns. Zurich-Swiss Reinsurance Company, Zurich
48. Higgins E et al (1917) Siliceous dust in relation to pulmonary diseases among miners in the Joplin district, Missouri. Bulletin 132. US Department of Interior, Bureau of Mines, Washington
49. Hinds WC (1999) Aerosol technology, 2nd edn. Wiley, New York
50. Howard J (2011) Dynamic oversight: implementation gaps and challenges. J Nanopart Res 13:1427-1434
51. HSA (Health and Safety Authority) (2005) Safety, health and welfare act. HSA, London
52. HSE (2004) Nanotechnology. Horizons scanning information note no. HSIN1. Health and Safety Executive, London
53. HSE (2013) Your health, your safety: a brief guide for workers. HSE, London. http://www.hse.gov.uk/pubns/indg450.htm. Accessed 16 Aug 2013
54. ILO (2008) Seoul Declaration on Safety and Health at Work (2008). www.seouldeclaration.org. Accessed 16 Aug 2013
55. Interessengemieinschaft Detailhandel Schweiz (IG-DHS) (2013) Code of conduct for nanotechnologies. http://www.innovationsgesellschaft.ch/media/ archive2/publikationen/CoC-Nanotechnologies-english.pdf. Accessed 17 Jan 2013
56. International Council on Nanotechnology (ICON) (2006) A review of current practices in the nanotechnology industry. Phase two report: survey of current practices in the nanotechnology workplace. University of California Santa Barbara, Santa Barbara
57. Invernizzi N (2011) Nanotechnology between the lab and the shop floor: what are the effects on labor? J Nanopart Res 13:2249-2268. doi: 10.1007/s11051-011-0333-z
58. IOM (2000) Development of a biomathematical lung model to describe the exposure-dose relationship for inhaled dust among UK coal miners. In: Tran CL (ed) IOM Research Report TM/00/02. B.D., Institute of Occupational Medicine, Edinburgh
59. ISO (2007) Workplace atmospheres. Ultrafine nanoparticle and nano-structured aerosols: inhalation, exposure characterization and assessment. International Organization for Standardization, ISO/TR, Geneva, p 27628
60. ISO (2009) Guide to safe handling and disposal of manufactured nanomaterials, Draft report. ISO/TC 229 Nanotechnologies working group 3: health, safety and the environment, project group 6. International Organization for Standardization, Seattle
61. Jacobstein N (2006) Foresight guidelines for responsible nanotechnology development. https://www.foresight.org/guidelines/ForesightGuidelinesV6.pdf. Accessed 16 Aug 2013
62. Jones RM, Nicas M (2006) Margins of safety provided by COSHH essentials and the ILO chemical control toolkit. Ann Occup Hyg 50(2):149-156
63. Jonsen AR (1991) Ethical considerations and responsibilities when communicating health risk information. J Clin Epidemiol 44:69-72
64. Karn B, Bergeson L (2009) Green nanotechnology: straddling promise and uncertainty. American Bar Association, Natural Resource & Environment, Fall 2009, Vol. 24, Issue 2
65. Kreider T, Halperin W (2011) Engineered nanomaterials: learning from the past, planning for the future. J Occup Environ Med 53(6):S108-S112
66. Kuempel ED, Tran CL, Castranova V, Bailer AJ (2006) Lung dosimetry and risk assessment of nanoparticles: evaluating and extending current models in rats and humans. Inhal Toxicol 18(10):717-724
67. Kuempel ED, Geraci CL, Schulte PA (2012a) Risk assessment and risk management of nanomaterials in the workplace: translating research to practice. Ann Occup Hyg 56(5):491-505
68. Kuempel ED, Castranova V, Geraci CL, Schulte PA (2012b) Development of risk-based nanomaterial groups for occupational exposure control. J Nanopart Res 14(9):1029
69. Kulinowski K, Lippy B (2012) Training workers on risks of nanotechnology. National Institutes of Health, National Institute of Environmental Health Sciences, Bethesda, p 43
70. Lee JH, Kuk WK, Kwon M, Lee JH, Lee KS, Yu IJ (2012) Evaluation of information in nanomaterial safety data sheets and development of international standards for guidance on preparation of nanomaterial safety data sheets. Nanotoxicology 7(3):338-345
71. Li N, Nel AE (2011) Feasibility of biomarker studies for engineered nanoparticles: what can be learned from air pollution research? J Occup Environ Med 53(6):S74-S79
72. Ling M-P, Lin W-C, Liu CC, Huang Y-S, Chues M-J, Shih T-S (2012) Risk management strategy to increase the safety of workers in the nanomaterials industries. J Hazard Mater 229(230):83-93
73. Liou S-H, Lin M-H, Hse C-H, Tsoou CJ, Li H-L, Li W-F, Lin P-P, Li L-A (2011) The pilot study of specific biomarkers in a health effects among engineered nanoparticle. Epidemiology 22:s254-s255
74. Luigi F (2009) Responsible care and nanomaterials case study: Nanocyl. In: Proceedings of the European responsible care conference. http://www.cefic.org/Documents/ResponsibleCare/04-Nanocyl.pdf. Accessed 3 Dec 2013
75. Maiello ML, Hoover MD (eds) (2011) Radioactive air sampling methods. CRC Press, Boca Raton
76. Maynard AD (2006) Nanotechnology: assessing the risks. Nano Today 1(2):22-33
77. Maynard AD, Kuempel ED (2005) Airborne nanostructured particles and occupational health. J Nanopart Res 7(6):587-614
78. McKinney W, Chen B, Frazer D (2009) Computer controlled multi-walled carbon nanotube inhalation exposure system. Inhal Toxicol 21(12):1053-1061
79. Merget R, Bauer T, Kupper HU, Philippou S, Bauer HD, Breitstadt R, Bruening T (2002) Health hazards due to inhalation of amorphous silica. Arch Toxicol 75:625-634
80. Murashov V, Howard J (2008) The US must help set international standards for nanotechnology. Nat Nanotechnol 3(11):635-636
81. Murashov V, Howard J (2013) Protecting nanotechnology workers while waiting for Godot. J Occup Environ Hyg 10(8):D116-D117
82. Murashov V, Schulte PA, Geraci C, Howard J (2011) Regulatory approaches to worker protection in nanotechnology industry in the USA and European Union. Ind Health 49(3):280-296
83. Murashov V, Schulte PA, Howard J (2012) Progression of occupational risk management with advances in nanomaterials. J Occup Environ Hyg 9(1):D12-D22
84. Nakanishi J (ed) (2011a) Risk assessment of manufactured nanomaterials: approaches. Overview of approaches and results. NEDO, Kawasaki City, Japan
85. Nakanishi J (ed) (2011b) Risk assessment of manufactured nanomaterials: carbon nanotubes (CNT). NEDO, Kawasaki City, Japan
86. Nano Risk Framework (2007) www.NanoriskFramework.com. Accessed 3 Dec 2013
87. Nanocyl (2009) Responsible care and nanomateials case study nanocyl. Presentation at European responsible care conference, Prague 21-23rd October, 2009. http://www.cefic.be/Files/Downloads/04-Nanocyl.pdf. Accessed 23 Apr 2010
88. Nanosafe (2008) Nanosafe2: Efficiency of fibrous filters and personal protective equipment against nanoaerosols. Paper presented at the Nanosafe 2008, 3-7 November 2008, Grenoble
89. National Academy of Engineering (2004). Emerging technologies and ethical issues in engineering: papers from a workshop, 14-15 October 2003. National Academies Press, Washington
90. Naumann BD, Sargent EV, Starkman BS, Fraser WJ, Becker GT, Kirk GD (1996) Performance-based exposure control limits for pharmaceutical active ingredients. Am Ind Hyg Assoc J 57(1):33-42
91. Nel A, Xia T, Meng H, Wang X, Lin S, Ji Z, Zhang H (2013) Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening. Acc Chem Res 46:607-621
92. NIOSH (2002) Hazard review: health effects of occupational exposure to respirable crystalline silica. US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH), Cincinnati, p 129
93. NIOSH (2005) Approaches to Safe Nanotechnology: An Information Exchange with NIOSH. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Draft report for public review, Cincinnati
94. NIOSH (2009a) Notification on precautionary measures for prevention of exposures to nanomaterials. Japan NIOSH Notification No. 0331013. Labour Standard Bureau, Ministry of Health, Labour and Welfare, Japan
95. NIOSH (2009b) Approaches to safe nanotechnology: managing the health and safety concerns associated with engineered nanomaterials. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH), Cincinnati, p 125
96. NIOSH (2009c) Qualitative risk characterization and management of occupational hazards: control banding (CB): a literature review and critical analysis. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH), Cincinnati, p 152
97. NIOSH (2009d) Current Intelligence Bulletin 60: Interim guidance for medical screening and hazard surveillance for workers potentially exposed to engineered nanoparticles. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH), Cincinnati, p 116
98. NIOSH (2011a) Current intelligence bulletin 64: coal mine dust exposures and associated Health outcomes: a review of information published since 1995. Occupational exposure to titanium dioxide. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH), Cincinnati
99. NIOSH (2011b) Current intelligence bulletin 63. Occupational exposure to titanium dioxide. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH), Cincinnati, p 160
100. NIOSH (2013a) Current intelligence bulletin 65. Occupational exposure to carbon nanotubes and nanofibers. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH), Cincinnati, p 145
101. NIOSH (2013b) Current strategies for engineering controls in nanomaterial production and downstream handling processes. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH), Cincinnati, p 102
102. NNI (2004) NNI strategic plan. National nanotechnology initiative, http://www.nano.gov/node/242. Accessed 3 Dec 2013
103. NNI (2011) National nanotechnology initiative strategic plan. National nanotechnology initiative. http://www.nano.gov/node/581. Accessed 3 Dec 2013
104. NRC (1983) Risk assessment in the federal government: managing the process. Committee on the Institutional Means for Assessment of Risks to Public Health, Commission on Life Sciences, National Research Council. National Academies Press, Washington
105. NRC (2009) Science and decisions: advancing risk assessment, committee on improving risk analysis approaches used by the U.S. EPA, Board on Environmental Studies and Toxicology, Division on Earth and Life Studies, National Research Council of the National Academies. National Academies Press, Washington
106. Oberdörster G, Yu CP (1990) The carcinogenic potential of inhaled diesel exhaust: a particle effect. J Åerosol Sci 21(S1):S397-S401
107. Oberdörster G, Ferin J, Soderholm S, Gelein R, Cox C, Baggs R, Morrow PE (1994) Increased pulmonary toxicity of inhaled ultrafine particles: due to lung overload alone? Ann Occup Hyg 38:295-302
108. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K et al (2005) Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Particle Fibre Toxicol 2:8
109. Oberdörster G, Stone V, Donaldson K (2007) Toxicology of nanoparticles: a historical perspective. Nanotoxicology 1(1):2-25
110. OECD (2007) Guidance on grouping of chemicals. Series on testing and assessment, no. 80. ENV/JM/MONO(2007)28. Organization for Economic Cooperation and Development, Environmental Health and Safety Publications, Paris
111. OECD (2010) List of manufactured nanomaterials and list of endpoints for phase one of the sponsorship programme for the testing of manufactured nanomaterials. http://search.oecd.org/officialdocuments/displaydocumentpdf/? cote=ENV/JM/MONO(2010)46&docLanguage=En. Accessed 13 Aug 2013
112. OSHA (2012) Hazard communication. 29CFR Parts 1910, 1915, and 19226. Fed Reg 77(58):17574-17892
113. OSHA (2013) OSHA fact sheet: Working safely with nanomaterials. OSHA, Washington
114. Ostiguy C, Riediker M, Triolet J, Troisfontaines P, Vernez D (2010) Development of a specific control banding tool for nanomaterials. Expert committee (CES) on physical agents. French Agency for Food, Environmental, and Occupational Health and Safety, Maisons-Alfort Cedex
115. Ostraat ML, Thornburg JW, Malloy GJ (2013) Measurement strategies of airborne nanomaterials. Environ Eng Sci 30:126-132
116. Paik SY, Zalk DM, Swuste P (2008) Application of a pilot control banding tool for risk level assessment and control of nanoparticle exposures. Ann Occup Hyg 52(6):419-428
117. Pelley J, Saner M (2009) International approaches to the regulatory governance of nanotechnology. Carleton University Regulatory Governance Initiative, Ottawa
118. Peterson JE (1973) Principles for controlling the occupational environment. The industrial environment - its evaluation and control. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH), Cincinnati, p 117
119. Philbrick M (2010) An anticipatory governance approach to carbon nanotubes. Risk Anal 30(11):1708-1722
120. Pidgeon N, Harthorn BH, Bryant K, Rogers-Hayden T (2008) Deliberating the risks of nanotechnologies for energy and health applications in the United States and United Kingdom. Nat Nanotech 4(2):95-98
121. Ponce Del Castillo A (2013) Nanomaterials and workplace health and safety: what are the issues for workers?. European Trade Union Institute, Brussels
122. Pope CA 3rd, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD (2002) Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 287(9):1132-1141
123. Ramachandran G, Ostraat MT, Evans DE, Methner MM, O'Shaughnessy P, D'Arcy J, Geraci C, Stevenson E, Maynard A, Rickabaugh K (2011) A strategy for assessing workplace exposure to nanomaterials. J Occup Environ Hyg 11:673-685
124. Reuzel PGJ, Bruijntjes JP, Feron VJ, Woutersen RA (1991) Subchronic inhalation toxicity of amorphous silicas and quartz dust in rats. Food Chem Toxicol 29(5):341-354. doi: 10.1016/0278-6915(91)90205-l
125. Riediker M, Schubauer-Berigan MK, Brouwer DH, Nelissen I, Koppen G, Frijns E et al (2012) A road map toward a globally harmonized approach for occupational health surveillance and epidemiology in nanomaterial workers. J Occup Environ Med 54(10):1214-1223
126. Roco MC (1997) Introduction. WTEC Workshop report on R&D status and trends in nanoparticles, nanostructured materials, and nanodevices in the United States. World Technology Evaluation Center (WTEC), Baltimore
127. Roco MC (2003) Societal implications of nanoscience and nanotechnology. In: Nanoscale Science Engineering and Technology (NSET) Workshop report, National Science Foundation, Arlington
128. Roco MC, Bainbridge WS (2003) Societal implications of nanoscience and nanotechnology: maximizing human benefit. J Nanoparticle Res 7:1-13
129. Roco MC, Harthorn B, Guston D, Shapria P (2011) Innovative and responsible governance of nanotechnology for societal development. J Nanopart Res. doi: 10.1007/S11051-011-0454-4
130. Royal Society and Royal Academy of Engineering (2004) Nanoscience and nanotechnologies: opportunities and uncertainties. Royal Society and Royal Academy of Engineering, London
131. Safe Work Australia (2010a) Work health and safety assessment tool for handling engineered nanomaterials. http://www.safeworkaustralia.gov.au/sites/ swa/about/publications/pages/at201008workhealthandsafetyassessmenttool. Accessed 14 Aug 2013
132. Safe Work Australia (2010b) An evaluation of MSDS and labels associated with the use of engineered nanomaterials. http://www.safeworkaustralia.gov.au/ sites/swa/about/publications/pages/rp201006evaluationofmsdsandlabels. Accessed 14 Aug 2013
133. Samuels SW (1986) The environment of the workplace and human value. Alan Liss Inc, New York
134. Sargent EV, Kirk GD (1988) Establishing airborne exposure control limits in the pharmaceutical industry. Am Ind Hyg Assoc J 49(6):309-313
135. Savolainen K (2012) Responsive development of nanotechnology. Barents Newsletter on Occupational Health and Safety 15:33-35
136. SCENIHR (2005) Request for a scientific opinion on the appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious nanotechnologies. Scientific Committee on Emerging and Newly Identified Health Risks, Brussels
137. Schulte PA, Iavicoli I (2012) Nanotechnology. International Commission on Occupational Health (ICOH) Newsletter, Paulo Vol 10, p 8-9
138. Schulte PA, Ringen K (1984) Notification of workers at high risk: an emerging public health problem. Am J Public Health 74(5):485-491
139. Schulte PA, Salamanca-Buentello F (2007) Ethical and scientific issues of nanotechnology in the workplace. Environ Health Perspect 115(1):5-12
140. Schulte PA, Trout DB (2011) Nanomaterials and worker health medical surveillance, exposure registries, and epidemiologic research. J Occup Environ Med 53(6):S3-S7
141. Schulte PA, Geraci CL, Zumwalde RD, Hoover M, Kuempel ED (2008a) Occupational risk management of engineered nanoparticles. J Occup Environ Hyg 5(4):239-249
142. Schulte PA, Rinehart R, Okun A, Geraci CL, Heidel DS (2008b) National prevention through design (PtD) initiative. J Saf Res 39(2):115-121
143. Schulte PA, Schubauer-Berigan MK, Mayweather C, Geraci CL, Zumwalde RD, McKernan JL (2009) Issues in the development of epidemiologic studies of workers exposed to engineered nanoparticles. J Occup Environ Med 51(3):323-335
144. Schulte PA, Murashov V, Zumwalde R, Kuempel ED, Geraci CL (2010) Occupational exposure limits for nanomaterials: state of the art. J Nanopart Res 12(6):1971-1987
145. Schulte PA, Mundt DJ, Nasterlack M, Mulloy KB, Mundt KA (2011) Exposure registries: overview and utility for nanomaterial workers. J Occup Environ Med 53(6):S42-S47
146. Schulte PA, Kuempel ED, Zumwalde RD, Geraci CL, Schubauer-Berigan MK, Castranova V et al (2012) Focused actions to protect carbon nanotube workers. Am J Ind Med 55(5):395-411
147. Seaton A, Tran L, Aitken R, Donaldson K (2010) Nanoparticles, human health hazard and regulation. J R Soc Interface 7(Suppl 1):S119-S129
148. Shatkin JA, Abbott LC, Bradley AE, Canady RA, Guidotti T, Kulinowski KM, Löfstedt R, Lonis G, MacDonell M, Maynard A, Paoli G, Shreemati L, Walker N, White R, Williams R (2010) Nano risk analysis: advancing the science for nanomaterials risk management. Risk Anal 11:1680-1687
149. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI et al (2005) Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 289(5):L698-L708
150. Stone V, Pozzi-Mucelli S, Tran L, Aschberger K, Sabella S, Vogel UB, Poland C, Balharry D, Fernandes T, Gottardo S, Hankin S, Hartl M, Hartmann N, Hristozov D, Hund-Rinke K, Johnston H, Marcomini A, Panzer O, Roncato D, Saber AT, Wallin H, Scott-Fordsmand JJ (2013) Research prioritisation to deliver an intelligent testing strategy for the human and environmental safety of nanomaterials. ITS-NANO. Institute of Occupational Medicine, Craig
151. Subramanian V, Youtie J, Porter AL, Shapira P (2010) Is there a shift to "active nanostructures"? J Nanopart Res 12(1):1-10
152. Tannert C, Elvers H-D, Jandrig B (2007) The ethics of uncertainty: in the light of possible dangers, research becomes a moral duty. EMBO Rep 8(10):892-896. doi: 10.1038/sj.embor.7401072
153. Tomellini R, Giordani J (2008) Third International Dialogue on Responsible Research and Development of Nanotechnology. European Commission, Brussels
154. Trout DB, Schulte PA (2010) Medical surveillance, exposure registries, and epidemiologic research for workers exposed to nanomaterials. Toxicology 269(2-3):128-135
155. TÜV SÜD Industrie Service GmbH (2013) Nanorisk check. http://www.tuev-sued.de/technical-installations/riskmanagement/nanotechnology/ nanorisk-check. Accessed 20 Aug 2013
156. UN Conference on Environment and Development (1992) Rio declaration on environment and development, Rio de Janeiro. http://www.un.org/documents/ga/ conf151/aconf15126-1annex1.htm. Accessed 16 Aug 2013
157. US-EU Cooperation on workplace safety and health (2012) Nanotechnology in the workplace. http://useuosh.org/conference2012/nanotechnology-whitepaper. html. Accessed 13 Aug 2013
158. van Broekhuizen P, van Broekhuizen F, Cornelissen R, Reijnders L (2012) Workplace exposure to nanoparticles and the application of provisional nanoreference values in times of uncertain risks. J Nanopart Res 14(4):1-25
159. VCI (2012) Responsible production and use of nanomaterials https://www.vci.de/Services/Leitfaeden/Seiten/Responsible-Production-and-Use-of- Nanomaterials.aspx. Accessed 14 Aug 2013
160. Winkler DA, Mombelli E, Pietroiusti A, Tran L, Worth A, Fadeel B, McCall MJ (2012) Applying quantitative structure-activity relationship approaches to nanotoxicology: current status and future potential. Toxicology 313(1):15-23
161. World Health Organization (WHO) (1994) Declaration on Occupational Health for All. World Health Organization, Geneva
162. Xia T, Meng H, George S, Zhang H, Wang X, Ji Z, Zink JI, Nel AE (2010) Strategy for toxicity screening of nanomaterials. Mater Matters 593:82-84
163. Yale Law Journal (1981) Occupational health risks and the workers' right to know. Yale Law J 90:1792-1810
164. Zhang QW, Kusaka Y, Donaldson K (2000) Comparative pulmonary responses caused by exposure to standard cobalt and ultrafine cobalt. J Occup Health 42(4):179-184
165. Zhang QW, Kusaka Y, Zhu XQ, Sato K, Mo YQ, Kluz T et al (2003) Comparative toxicity of standard nickel and ultrafine nickel in lung after intratracheal instillation. J Occup Health 45(1):23-30